Managing Filler Vascular Occlusion

Vascular occlusion caused by cross-linked hyaluronic acid filler is the failure this notebook guards against. It is the complication a new injector should be able to name before the first treatment, not after it.

PubMed Central carries a paper that states its purpose plainly: "This paper provides guidance on how to identify and manage a vascular occlusion caused by cross-linked hyaluronic acid." The full text is the guideline for the management of hyaluronic acid filler-induced vascular occlusion, and it is the reference to read alongside these pages.

For clinicians near Parsippany, New Jersey who are preparing for a first filler course, this is a topic to settle before the course certificate arrives.

From recognition to response

Read these two in order. You cannot respond to what you have not recognized.

Recognizing signs of tissue ischemia covers how to tell that tissue is in trouble after an injection.

Hyaluronidase as first-line treatment covers hyaluronidase as the first response once the problem is recognized.

Recognition, first response and the written plan

Before treating a patient in this area, a clinician should be able to say what vascular occlusion looks like, what the first response is, and where that response is written down. The American Society of Plastic Surgeons also publishes a page on dermal filler risks and safety that is worth keeping in view.